ERNEST CHEMIST in collaboration with Merck Pty (Ltd), a South African drug producing company, has introduced IIiadin, a product expected to aid rapid relief of nasal congestion, onto the market.
The product's comprehensive range consists of Iliadin, which contains oxymetazoline for clearing a blocked nose caused by the common cold, sinusitis, allergic rhinitis and hay fever, and Iliadin Saline, which is designed to soothe dry nasal passages naturally.
Launching the product, Dr. Duane Mol, an Ear, Nose and Throat (ENT) specialist from South Africa observed that to assist with decongestion, the oxymetazoline in Iliadin reduces swelling of the nasal passages and unblocks the nose within a few seconds.
Dr. Mol further noted that prioritising health and well-being is a growing trend among many consumers in Africa, adding that it is against this background that Merck Consumer Healthcare has introduced international brands and local innovations that are trusted by consumers and backed by science in Ghana.
'The Consumer Healthcare division operates on all continents, including Africa. Merck's over-the-counter offerings include cold and flu remedies, vitamins and minerals to keep people active and moving, as well as specially formulated supplements for diabetics,' he explained.
He said that stuffy noses can cause a great deal of discomfort, and can have a variety of causes since seasonal allergies, commonly called hay fever, are widespread.
He also stated that it occurs only during certain times of the year depending on what a person is allergic to. Another cause is rhinitis, which is inflammation and swelling of the mucous membrane of the nose, characterised by a runny nose and stuffiness, and is usually caused by the common cold or an allergy.
'The range of Iliadin products' launching in Ghana will offer relief to many desperate consumers,' says Jolene Bellingan, Product Manager for Merck.
By Ruth Oppong-Nyarko